| NCT07189871 | 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors | NOT_YET_RECRUITING | PHASE1, PHASE2 | 2025-11 | 2027-12 | 2027-12 |
| NCT06824155 | HEAT Trial (HER2 Antibody Therapy With Lutetium-177) | RECRUITING | EARLY_PHASE1 | 2025-02-12 | 2027-09 | 2027-09 |
| NCT06777433 | Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases | RECRUITING | PHASE2 | 2024-12-13 | 2026-06 | 2026-01 |
| NCT06305962 | 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors | RECRUITING | EARLY_PHASE1 | 2024-06-03 | 2025-10 | 2025-07 |
| NCT05799274 | Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer | RECRUITING | PHASE1 | 2023-11-09 | 2025-11 | 2025-11 |